Article Details
Retrieved on: 2024-02-17 21:30:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Silverback Therapeutics Inc., a biopharmaceutical company listed on NASDAQ, emphasizing stock performance, institutional investments (e.g., BlackRock), and the stock's rating by analysts in the fintech and stock market sectors.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here